As upfront negotiations wrap up, experts from Mediaplus and Jellyfish spoke about the overarching themes from this year.

Trump’s executive order to separate combination shots will drive up drugmaker costs; The Supreme Court declined Eli Lilly’s ...

Rather than hand the naming process to a small executive committee, Ingenyx and Matchstick built a survey and naming portal ...

Adam Wyldeck joined AstraZeneca as head of corporate affairs, U.S. Biopharma. Quanterix hired Jim Gute as chief commercial ...

WPP has more than doubled its incentive pool in the first half of 2026 to £130m, up by 120.3% year on year. It follows a 2.8% ...

President Trump signs executive order changing childhood vaccination schedules; Plans are nearly finalized for Luigi Mangione ...

Bristol Myers Squibb megamerger continue to circulate; Amgen becomes latest in list of health companies announcing major data ...

The Detroit Pistons point guard discusses his partnership with Thorne, the difference between an endorsement and an ...

The steady creep of healthcare costs is top of mind not just in Asheville but for most U.S. voters, according to an April KFF poll. Nearly two-thirds of U.S. adults were worried about being able to ...

A state law passed in 2024 forced hospitals to remove a key drug — misoprostol — from the medical cart and keep it locked in ...

The FDA approved Moderna’s mRNA-based flu vaccine; Erica Schwartz was confirmed as director of the CDC; Another child died ...

AstraZeneca and Bristol Myers Squibb merger talks are off — or never existed; Senate scrutiny of Fauci could scare off ...